The tech giant said it would close the Amazon Care service by the end of the year as it retools its healthcare offerings following the purchase of primary-care company One Medical. Read More...
Reuters
Bavarian Nordic vows to boost monkeypox vaccine supply to combat shortfall
COPENHAGEN/LONDON (Reuters) -Bavarian Nordic, the maker of the only approved monkeypox vaccine, said on Wednesday it was exploring the viability of using technically expired doses to help bridge a growing gap between demand and supply due to the current outbreak. In an interview with Reuters, Chief Executive Paul Chaplin said global demand for the vaccine is “exceeding our ability to deliver”. More than 40,000 confirmed cases of monkeypox, including a handful of deaths, in over 80 countries where the virus is not endemic have been reported since early May. About a third of the current global case count is in the United States.
